Streetbeat News

Products Services

SONY

Insomniac, the game developer behind 'Marvel's Spider-Man 2', has released the game's launch trailer ahead of its exclusive release on Sony's PlayStation 5 on Oct. 20. The trailer reveals new villains and plot twists, and suggests that the character Peter Parker might take on the persona of Venom. Early reviews for the game are positive, with a Metacritic score of 91 based on 119 critic reviews.

Portfolio Pulse from Franca Quarneti

October 16, 2023 | 5:53 pm

SNAP

Snap Inc. (NASDAQ:SNAP) shares are trading higher after The Verge reported the company's internal goals for 2024. The goals include growing daily active users to 475+ million, increasing content viewers to 80% of DAU, and achieving $500 million of adjusted EBITDA and positive free cash flow. Snap is expected to report its Q3 financial results on Oct. 24.

Portfolio Pulse from Erica Kollmann

October 16, 2023 | 5:10 pm

AMZN

PTON

WMT

Amazon's Prime Big Deal Days event saw a significant increase in sales and daily active users (DAUs) compared to last year, despite consumer spending challenges. Analyst Nicholas Jones from JMP Securities reiterated Amazon with a Market Outperform and a $175 price target. The event also saw over 150 million items sold from third-party sellers, which could boost Amazon's 4Q margins. Peloton also saw an increase in purchases on Amazon during the event. However, Jones does not view the event as a significant incremental benefit to Amazon's revenue.

Portfolio Pulse from Anusuya Lahiri

October 16, 2023 | 5:09 pm

FFIV

MRVL

Marvell (MRVL), F5 Networks (FFIV), and Arm have announced a collaboration to enable the first open programmable infrastructure project demonstration at the 2023 OCP Global Summit. The terms of the collaboration were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 5:05 pm

GOOG

META

MSFT

Meta Platforms Inc (NASDAQ:META) highlighted its focus on artificial intelligence (AI) at its annual Connect conference, with emphasis on its large language model (LLM), Llama. Llama is seen as an open-source counterpart to Microsoft Corp's (NASDAQ: MSFT) GPT and Alphabet Inc's (NASDAQ: GOOG) (NASDAQ: GOOGL) Google's PaLM 2. Despite the costs associated with AI research, Meta believes Llama will reshape the LLM landscape and lead to cost savings. However, some industry players find Meta's licensing terms for Llama 2 restrictive.

Portfolio Pulse from Anusuya Lahiri

October 16, 2023 | 5:05 pm

ACHR

STLA

Archer Aviation Inc (ACHR) has entered into an agreement with the Abu Dhabi Investment Office (ADIO) to launch its all-electric air taxi service across the UAE. Archer plans to commence operations in Abu Dhabi in 2026 and will establish its first international headquarters and manufacturing facilities in the city. The company will work with its global manufacturing partner Stellantis N.V. (STLA) and local partners in the UAE to build its aircraft manufacturing capabilities. ACHR shares are trading higher by 2.45% at $5.24.

Portfolio Pulse from Shivani Kumaresan

October 16, 2023 | 4:40 pm

APTO

Aptose Biosciences announced that two abstracts on tuspetinib, its Phase 1/2 myeloid kinase inhibitor in development for acute myeloid leukemia, have been released. This news has led to an increase in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 4:24 pm

AZN

BIOVF

PFE

SNY

Healthcare providers are facing challenges in offering Pfizer's Abrysvo and Sanofi's Beyfortus, treatments for respiratory syncytial virus (RSV) in infants, due to insurance coverage issues and high costs. RSV is a significant threat to newborns, seniors, and adults with chronic conditions. The only previous preventative measure was Swedish Orphan Biovitrum's Synagis, costing about $1,000 per dose. Abrysvo and Beyfortus reduce the risk of severe disease or hospitalization by over 50%.

Portfolio Pulse from Vandana Singh

October 16, 2023 | 4:16 pm

Boeing predicts that air traffic and fleet growth in Northeast Asia will outpace economic expansion over the next 20 years. The region is expected to take delivery of 1,350 commercial jets, with a high proportion of widebodies, by 2042. The forecast shows 70% of demand replacing the current fleet, improving sustainability and airline competitiveness.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 4:02 pm

DARE

Dare Bioscience announced the achievement of its first commercial milestone under license agreement for XACIATO vaginal gel, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 3:59 pm